Live Status Check

NCT05850234 Recruiting Status

Real-time enrollment status for this multiple myeloma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 11:51 AM UTC

NCT05850234 Status Summary

NCT NumberNCT05850234
Recruiting StatusRecruiting
ConditionMultiple Myeloma
PhaseClinical Trial
Target Enrollment80 participants
Active Locations37 sites in the US
SponsorAstraZeneca
Last Updated on CT.govAugust 6, 2025 (Aug 6, 2025)

About NCT05850234 Enrollment Status

As of March 2, 2026: Clinical trial NCT05850234 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 37 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05850234

Is NCT05850234 still recruiting?

Yes, NCT05850234 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05850234 recruiting?

This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05850234?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05850234 status last updated?

The official ClinicalTrials.gov record for NCT05850234 was last updated Aug 6, 2025 (August 6, 2025). HelloStudys verifies this status automatically.

Browse More Multiple Myeloma Trials

Ready to Apply?

Check your eligibility for this clinical trial